Advanced search
Publication Cover
Drug Delivery Volume 24, 2017 - Issue 1
Submit an article Journal homepage
2,346
Views
19
CrossRef citations to date
0
Altmetric
Research Article

PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations

Xin Wang1 Department of pharmaceutics, School of Pharmacy, Chongqing Medical University, Chongqing, P. R. China and ;2 Chongqing Research Center for Pharmaceutical Engineering, Chongqing, P. R. China
,
Hua Huang1 Department of pharmaceutics, School of Pharmacy, Chongqing Medical University, Chongqing, P. R. China and ;2 Chongqing Research Center for Pharmaceutical Engineering, Chongqing, P. R. China
,
Liangke Zhang1 Department of pharmaceutics, School of Pharmacy, Chongqing Medical University, Chongqing, P. R. China and ;2 Chongqing Research Center for Pharmaceutical Engineering, Chongqing, P. R. China
,
Yan Bai1 Department of pharmaceutics, School of Pharmacy, Chongqing Medical University, Chongqing, P. R. China and ;2 Chongqing Research Center for Pharmaceutical Engineering, Chongqing, P. R. China
&
Huali Chen1 Department of pharmaceutics, School of Pharmacy, Chongqing Medical University, Chongqing, P. R. China and ;2 Chongqing Research Center for Pharmaceutical Engineering, Chongqing, P. R. ChinaCorrespondence[email protected]
Pages 339-345 | Received 14 Sep 2016, Accepted 23 Oct 2016, Published online: 06 Feb 2017

References

  • Banks WA, Robinson SM, Nath A. (2005). Permeability of the blood-brain barrier to HIV-1 Tat. Exp Neurol 193:218–27
  • Barry MA, Dower WJ, Johnston SA. (1996). Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries . Nat Med 2:299–305
  • Bazile D, Prud′homme C, Bassoullet MT, et al. (1995). PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci 84:493–8
  • Dasa SS, Suzuki R, Gutknecht M, et al. (2015). Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction. J Control Release 220:556–67
  • Ferrante EA, Pickard JE, Rychak J, et al. (2009). Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. J Control Release 140:100–7
  • Fittipaldi A, Giacca M. (2005). Transcellular protein transduction using the Tat protein of HIV-1. Adv Drug Deliv Rev 57:597–608
  • Ishida T, Iden DL, Allen TM. (1999). A combinatorial approach to producing sterically stabilized (Stealth) immunol liposomal drugs. FEBS Lett 460:129–33
  • Joliot A, Prochiantz A. (2004). Transduction peptides: from technology to physiology. Nat Cell Biol 6:189–96
  • Katanasaka Y, Ida T, Asai T, et al. (2008). Antiangiogenic cancer therapy using tumor vasculature-targeted liposomes encapsulating 3-(3,5-dimethyl-1H-pyrrol-2-ylmethylene)-1,3-dihydro-indol-2-one, SU5416. Cancer Lett 270:260–8
  • Kluza E, Jacobs I, Hectors SJ, et al. (2012). Dual-targeting of αvβ3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo. J Control Release 158:207–14
  • Ko YT, Hartner WC, Kale A, et al. (2009). Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide. Gene Ther 16:52–9
  • Koren E, Apte A, Sawant RR, et al. (2011). Cell-penetrating TAT peptide in drug delivery systems: proteolytic stability requirements. Drug Deliv 18:377–84
  • Li H, Yuan D, Sun M, et al. (2016). Effect of ligand density and PEG modification on octreotide-targeted liposome via somatostatin receptor in vitro and in vivo. Drug Deliv 15:1–11
  • Liang W, Levchenko T, Khaw BA, et al. (2004). ATP-Containing immunoliposomes specific for cardiac myosin. Curr Drug Deliv 1:1–7
  • Liu M, Li M, Sun S, et al. (2014). The use of antibody modified liposomes loaded with AMO-1 to deliver oligonucleotides to ischemic myocardium for arrhythmia therapy. Biomaterials 35:3697–707
  • McGuire MJ, Samli KN, Johnston SA, et al. (2004). In vitro selection of a peptide with high selectivity for cardiomyocytes in vivo. J Mol Biol 342:171–82
  • Nam HY, McGinn A, Kim PH, et al. (2010). Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium. Biomaterials 31:8081–7
  • Noble GT, Stefanick JF, Ashley JD, et al. (2014). Ligand-targeted liposome design: challenges and fundamental considerations. Trends Biotechnol 32:32–45
  • Sawant RR, Torchilin VP. (2012). Challenges in development of targeted liposomal therapeutics. AAPS J 14:303–15
  • Schwartz JJ, Zhang S. (2000). Peptide-mediated cellular delivery. Curr Opin Mol Ther 2:162–7
  • Scott RC, Rosano JM, Ivanov Z, et al. (2009). Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function. FASEB J 23:3361–7
  • Steenpass T, Lung A, Schubert R. (2006). Tresylated PEG-sterols for coupling of proteins to preformed plain or PEGylated liposomes. Biochim Biophys Acta 1758:20–8
  • Sutton MG, Sharpe N. (2000). Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101:2981–8
  • Torchilin VP. (2008). TAT peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv Drug Deliv Rev 60:548–58
  • Warren RA, Green FA, Enns CA. (1997). Saturation of the endocytic pathway for the transferrin receptor does not affect the endocytosis of the epidermal growth factor receptor. J Biol Chem 272:2116–21
  • Won YW, Bull DA, Kim SW. (2014). Functional polymers of gene delivery for treatment of myocardial infarct. J Control Release 195:110–19
  • Yuan M, Qiu Y, Zhang L, et al. (2016). Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma. Drug Deliv 23:1171–83

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.